Slideshow

The Year in Rheumatology

In this slideshow, we revisit some of our most popular stories of the year:  Insurers weigh in on step therapy,  a workable treatment was discovered for systemic sclerosis lung disease, treatment guidelines were penned for JIA-related uveitis, conflicting studies were published on treatments that may (or, may not) cause deadly infections, among others.

In this slideshow, we revisit some of our most popular stories of the year:  Insurers weigh in on step therapy,  a workable treatment was discovered for systemic sclerosis lung disease, treatment guidelines were penned for JIA-related uveitis, conflicting studies were published on treatments that may (or, may not) cause deadly infections, among others. 

Related Videos
Identifying B-cell Depleting Agents for Lupus Nephritis, with Richard Furie, MD
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
© 2025 MJH Life Sciences

All rights reserved.